Application of Radiosensitizers in Cancer Radiotherapy

被引:338
作者
Gong, Liuyun [1 ]
Zhang, Yujie [2 ,3 ]
Liu, Chengcheng [2 ]
Zhang, Mingzhen [2 ,3 ]
Han, Suxia [1 ]
机构
[1] Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 1, Xian 710061, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Sch Basic Med Sci, Xian 710061, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis, Minist Educ, Xian 710061, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
radiosensitizers; cancer radiotherapy; therapeutics; nanomedicine; mechanism; CELL LUNG-CANCER; LOCALLY ADVANCED HEAD; PHASE-III TRIAL; FACTOR-KAPPA-B; NITRIC-OXIDE; RADIATION-THERAPY; NECK-CANCER; PROSTATE-CANCER; ACCELERATED RADIOTHERAPY; CONTRAST AGENT;
D O I
10.2147/IJN.S290438
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Radiotherapy (RT) is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Although great success has been achieved on radiotherapy, there is still an intractable challenge to enhance radiation damage to tumor tissue and reduce side effects to healthy tissue. Radiosensitizers are chemicals or pharmaceutical agents that can enhance the killing effect on tumor cells by accelerating DNA damage and producing free radicals indirectly. In most cases, radiosensitizers have less effect on normal tissues. In recent years, several strategies have been exploited to develop radiosensitizers that are highly effective and have low toxicity. In this review, we first summarized the applications of radiosensitizers including small molecules, macromolecules, and nanomaterials, especially those that have been used in clinical trials. Second, the development states of radiosensitizers and the possible mechanisms to improve radiosensitizers sensibility are reviewed. Third, the challenges and prospects for clinical translation of radiosensitizers in oncotherapy are presented.
引用
收藏
页码:1083 / 1102
页数:20
相关论文
共 223 条
[1]   ELECTRON AFFINIC SENSITIZATION .2. PARA-NITROACETOPHENONE - RADIOSENSITIZER FOR ANOXIC BACTERIAL AND MAMMALIAN CELLS [J].
ADAMS, GE ;
ASQUITH, JC ;
DEWEY, DL ;
FOSTER, JL ;
MICHAEL, BD ;
WILLSON, RL .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY AND RELATED STUDIES IN PHYSICS CHEMISTRY AND MEDICINE, 1971, 19 (06) :575-&
[2]   CHEMICAL RADIOSENSITIZATION OF HYPOXIC CELLS [J].
ADAMS, GE .
BRITISH MEDICAL BULLETIN, 1973, 29 (01) :48-53
[3]   Nuclear factor-κ-B:: The enemy within [J].
Aggarwal, BB .
CANCER CELL, 2004, 6 (03) :203-208
[4]   The role of hypoxia inducible factor-1 in cell metabolism -: a possible target in cancer therapy [J].
Aiba, Rachicla S. Bel ;
Dimova, Elitsa Y. ;
Goerlach, Agnes ;
Kietzmann, Thomas .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (04) :583-599
[5]   Hypoxia-Modified Cancer Cell Metabolism [J].
Al Tameemi, Wafaa ;
Dale, Tina P. ;
Al-Jumaily, Raked M. Kh ;
Forsyth, Nicholas R. .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2019, 7
[6]   Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: Results of a phase I study [J].
Albertella, Mark R. ;
Loadman, Paul M. ;
Jones, Philip H. ;
Phillips, Roger M. ;
Rarnpling, Roy ;
Burnet, Neil ;
Alcock, Chris ;
Anthoney, Alan ;
Vjaters, Egils ;
Dunk, Chris R. ;
Harris, Peter A. ;
Wong, Alvin ;
Lalani, Alshad S. ;
Twelves, Chris J. .
CLINICAL CANCER RESEARCH, 2008, 14 (04) :1096-1104
[7]   Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action [J].
Aung, Thazin Nwe ;
Qu, Zhipeng ;
Kortschak, R. Daniel ;
Adelson, David L. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (03)
[8]   Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy [J].
Barbuti, Anna Maria ;
Chen, Zhe-Sheng .
CANCERS, 2015, 7 (04) :2360-2371
[9]   The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence [J].
Barker, Holly E. ;
Paget, James T. E. ;
Khan, Aadil A. ;
Harrington, Kevin J. .
NATURE REVIEWS CANCER, 2015, 15 (07) :409-425
[10]   Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism [J].
Benej, Martin ;
Hong, Xiangqian ;
Vibhute, Sandip ;
Scott, Sabina ;
Wu, Jinghai ;
Graves, Edward ;
Le, Quynh-Thu ;
Koong, Albert C. ;
Giaccia, Amato J. ;
Yu, Bing ;
Chen, Shih-Ching ;
Papandreou, Ioanna ;
Denko, Nicholas C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (42) :10756-10761